SCHEMBL8330628

SCHEMBL8330628

CCOCCC(C(=O)OCC)C(=O)SCC

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.37
TSHR P16473 3/20 0.37
TDP1 Q9NUW8 5/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
L3MBTL1 Q9Y468 5/20 0.35
MAPK1 P28482 3/20 0.35
LMNA P02545 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
THRB P10828 1/20 0.33
MMP8 P22894 1/20 0.33
POLB P06746 1/20 0.32
CPB2 Q96IY4 1/20 0.32
MAPT P10636 1/20 0.31
CRHBP P24387 1/20 0.31
CRHR2 Q13324 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7486384 0.83 TDP1 (0.47) ALDH1A1TSHRTDP1MEN1KMT2A
SCHEMBL8331526 0.80 ALDH1A1 (0.48) ALDH1A1TSHRTDP1MEN1KMT2A
SCHEMBL8330632 0.77 ALDH1A1 (0.41) ALDH1A1TSHRTDP1MEN1KMT2A
SCHEMBL9518730 0.75 L3MBTL1 (0.49) ALDH1A1TSHRTDP1MEN1KMT2A
SCHEMBL10850237 0.75 L3MBTL1 (0.49) ALDH1A1TSHRTDP1MEN1KMT2A
SCHEMBL24506841 0.74 ALDH1A1 (0.38) ALDH1A1TSHRTDP1MEN1KMT2A
SCHEMBL8329597 0.72 TDP1 (0.57) ALDH1A1TSHRTDP1MEN1KMT2A
SCHEMBL30932946 0.71 L3MBTL1 (0.44) ALDH1A1TSHRTDP1MEN1KMT2A
SCHEMBL20782771 0.71 ALDH1A1 (0.36) ALDH1A1TSHRTDP1MEN1KMT2A
SCHEMBL3328503 0.71 ALDH1A1 (0.44) ALDH1A1TSHRTDP1MAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5908863-A ANTIGROWTH AGENT FOR BONES DOMPE' S.P.A. (IT) 1999-06-01 US disclosed
EP-0792878-A2 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism Dompé S.P.A. (IT) 1997-09-03 EP disclosed